METHODS: This analysis includes data from 318 patients treated for SGC between 1992 and 2020. Survival analysis was performed using the Kaplan-Meier method. Univariate and multivariate analyses were used to identify risk factors associated with recurrence.
RESULTS: 21.7% of the patients developed recurrent disease after a mean of 38.2 months. In multivariate analysis, positive-resection margins, vascular invasion, and tumor localization in the submandibular gland and small salivary glands were independent factors for recurrence. The 5-year overall survival was 67%, the 5-year disease-free survival was 54%.
CONCLUSIONS: Tumor recurrence in SGC occurred in one out of five patients. In highly aggressive entities and patients with risk factors, treatment intensification should be considered.
方法:该分析包括来自1992年至2020年间接受SGC治疗的318名患者的数据。使用Kaplan-Meier方法进行生存分析。使用单变量和多变量分析来确定与复发相关的危险因素。
结果:21.7%的患者在平均38.2个月后出现疾病复发。在多变量分析中,切缘阳性,血管浸润,下颌下腺和小唾液腺的肿瘤定位是复发的独立因素。5年总生存率为67%。5年无病生存率为54%.
结论:5例患者中有1例发生SGC肿瘤复发。在高度攻击性的实体和有危险因素的患者中,应考虑加强治疗。